229 related articles for article (PubMed ID: 10893334)
1. Plasma FFA utilization and fatty acid-binding protein content are diminished in type 2 diabetic muscle.
Blaak EE; Wagenmakers AJ; Glatz JF; Wolffenbuttel BH; Kemerink GJ; Langenberg CJ; Heidendal GA; Saris WH
Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E146-54. PubMed ID: 10893334
[TBL] [Abstract][Full Text] [Related]
2. Weight reduction and the impaired plasma-derived free fatty acid oxidation in type 2 diabetic subjects.
Blaak EE; Wolffenbuttel BH; Saris WH; Pelsers MM; Wagenmakers AJ
J Clin Endocrinol Metab; 2001 Apr; 86(4):1638-44. PubMed ID: 11297597
[TBL] [Abstract][Full Text] [Related]
3. Fasting increases plasma membrane fatty acid-binding protein (FABP(PM)) in red skeletal muscle.
Turcotte LP; Srivastava AK; Chiasson JL
Mol Cell Biochem; 1997 Jan; 166(1-2):153-8. PubMed ID: 9046032
[TBL] [Abstract][Full Text] [Related]
4. The fate of [U-(13)C]palmitate extracted by skeletal muscle in subjects with type 2 diabetes and control subjects.
Blaak EE; Wagenmakers AJ
Diabetes; 2002 Mar; 51(3):784-9. PubMed ID: 11872680
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenergically stimulated fat oxidation is diminished in middle-aged compared to young subjects.
Blaak EE; van Baak MA; Saris WH
J Clin Endocrinol Metab; 1999 Oct; 84(10):3764-9. PubMed ID: 10523027
[TBL] [Abstract][Full Text] [Related]
6. Training-induced elevation in FABP(PM) is associated with increased palmitate use in contracting muscle.
Turcotte LP; Swenberger JR; Tucker MZ; Yee AJ
J Appl Physiol (1985); 1999 Jul; 87(1):285-93. PubMed ID: 10409586
[TBL] [Abstract][Full Text] [Related]
7. Increase in skeletal muscle fatty acid binding protein (FABPC) content is directly related to weight loss and to changes in fat oxidation following a very low calorie diet.
Blaak EE; Glatz JF; Saris WH
Diabetologia; 2001 Nov; 44(11):2013-7. PubMed ID: 11719832
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of forearm glucose and free fatty acid (FFA) disposal in normal subjects and type II diabetic patients: evidence against an essential role for FFA in the pathogenesis of insulin resistance.
Capaldo B; Napoli R; Di Marino L; Picardi A; Riccardi G; Sacca L
J Clin Endocrinol Metab; 1988 Nov; 67(5):893-8. PubMed ID: 3053749
[TBL] [Abstract][Full Text] [Related]
9. Impaired oxidation of plasma-derived fatty acids in type 2 diabetic subjects during moderate-intensity exercise.
Blaak EE; van Aggel-Leijssen DP; Wagenmakers AJ; Saris WH; van Baak MA
Diabetes; 2000 Dec; 49(12):2102-7. PubMed ID: 11118013
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic stimulation of energy expenditure and forearm skeletal muscle metabolism in lean and obese men.
Blaak EE; Van Baak MA; Kemerink GJ; Pakbiers MT; Heidendal GA; Saris WH
Am J Physiol; 1994 Aug; 267(2 Pt 1):E306-15. PubMed ID: 7915493
[TBL] [Abstract][Full Text] [Related]
11. Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley DE; Simoneau JA
J Clin Invest; 1994 Dec; 94(6):2349-56. PubMed ID: 7989591
[TBL] [Abstract][Full Text] [Related]
12. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects.
Wilmsen HM; Ciaraldi TP; Carter L; Reehman N; Mudaliar SR; Henry RR
Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E354-62. PubMed ID: 12700163
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients.
van Loon LJ; Manders RJ; Koopman R; Kaastra B; Stegen JH; Gijsen AP; Saris WH; Keizer HA
Diabetologia; 2005 Oct; 48(10):2097-107. PubMed ID: 16096823
[TBL] [Abstract][Full Text] [Related]
14. Substrate utilization in non-obese Type II diabetic patients at rest and during exercise.
Borghouts LB; Wagenmakers AJ; Goyens PL; Keizer HA
Clin Sci (Lond); 2002 Dec; 103(6):559-66. PubMed ID: 12444908
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle metabolic characteristics before and after energy restriction in human obesity: fibre type, enzymatic beta-oxidative capacity and fatty acid-binding protein content.
Kempen KP; Saris WH; Kuipers H; Glatz JF; Van Der Vusse GJ
Eur J Clin Invest; 1998 Dec; 28(12):1030-7. PubMed ID: 9893016
[TBL] [Abstract][Full Text] [Related]
16. Endurance training increases FFA oxidation and reduces triacylglycerol utilization in contracting rat soleus.
Dyck DJ; Miskovic D; Code L; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2000 May; 278(5):E778-85. PubMed ID: 10780932
[TBL] [Abstract][Full Text] [Related]
17. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action.
Loviscach M; Rehman N; Carter L; Mudaliar S; Mohadeen P; Ciaraldi TP; Veerkamp JH; Henry RR
Diabetologia; 2000 Mar; 43(3):304-11. PubMed ID: 10768091
[TBL] [Abstract][Full Text] [Related]
18. Substrate utilization and thermogenic responses to beta-adrenergic stimulation in obese subjects with NIDDM.
Blaak EE; Saris WH; Wolffenbuttel BH
Int J Obes Relat Metab Disord; 1999 Apr; 23(4):411-8. PubMed ID: 10340820
[TBL] [Abstract][Full Text] [Related]
19. Muscle oxidative capacity is a better predictor of insulin sensitivity than lipid status.
Bruce CR; Anderson MJ; Carey AL; Newman DG; Bonen A; Kriketos AD; Cooney GJ; Hawley JA
J Clin Endocrinol Metab; 2003 Nov; 88(11):5444-51. PubMed ID: 14602787
[TBL] [Abstract][Full Text] [Related]
20. Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy.
Catalano PM; Nizielski SE; Shao J; Preston L; Qiao L; Friedman JE
Am J Physiol Endocrinol Metab; 2002 Mar; 282(3):E522-33. PubMed ID: 11832353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
